Anniversary of the Launch of the Global Strategy for the Elimination of Cervical Cancer

Anniversary of the Launch of the Global Strategy for the Elimination of Cervical Cancer

Join us to celebrate the Anniversary of the Launch of the Global Strategy for the Elimination of Cervical Cancer on Wednesday, 17 November  2021, from 2:00 to 3:30 pm (EST).

The World Health Organization launched the Strategy to Accelerate the Elimination of Cervical Cancer on 17 November 2020. On its first anniversary, PAHO/WHO is organizing a virtual seminar to commemorate this day and review progress within the context of the initiative. The event will serve as an opportunity to share information and experiences implementing activities towards elimination in the region. Global goals towards the elimination of Cervical Cancer must be reinforced: 90% coverage of the HPV vaccine in girls before the age of 15; 70% coverage of screening with HPV test in women aged 35-45 years; and 90% coverage of treatment of cervical disease (pre-cancer and cancer), including palliative care.


How to participate


 The session will be available in English and Spanish with simultaneous translation.





In Portuguese at  





Moderator: Mauricio Maza Advisor on Cancer Prevention and Control (PAHO)

  • 2:00 PMWelcome remarks: Commitments to Eliminate Cervical Cancer in the Americas
    • Dr. Anselm Hennis–  Director, NonCommunicable Diseases and Mental Health Department (PAHO)
  • 2:05 PMOverview of Cervical Cancer Elimination Strategy
    • Mauricio Maza Advisor on Cancer Prevention and Control (PAHO);
  • 2:10 PM - Advances in HPV Immunization in the Americas: Updates on HPV immunization coverage – Impact of COVID-19 pandemic on the implementation of HPV vaccination programs in the Americas
    • Maria Teresa da Costa OliveiraImmunization Unit (PAHO)
  • 2:25 PM - Baseline Situation for Cervical Cancer Elimination: Analysis performed to understand the current context in the region based on most updated evidence
    • Raúl MurilloDirector Javeriano Center for OncologySan Ignacio University Hospital, Colombia
  • 2:35 PM - Antigua and Barbuda: Development of cervical cancer task force and path towards the implementation of HPV screening as part of the strategy to accelerate cervical cancer elimination
    • Cherie TullochTaskforce for the Elimination of Cervical Cancer, Antigua and Barbuda
  • 2:45 PMBrazil: Pilot project plans for implementation of HPV biomolecular tests within the context of a Pap smear system in the State of Pernambuco
    • Leticia KatzState of Pernambuco, Brazil
  • 2:55 PMParaguay: Steps for the transition from Pap testing to screening with HPV biomolecular tests within the context of cervical cancer elimination
    • Marina OrtegaMinistry of Health Paraguay
  • 3:05 PMCOVID-19 Project: Example of an initiative to counter the impact of COVID-19on care of women who require follow-up due to abnormal HPV screening results
    • Karla AlfaroBasic Health International
  • 3:15 PMELA2.0 Project: How virtual platforms can help cervical cancer elimination initiative
    • Melissa LopezMD Anderson Cancer Center
    • Sandra San MiguelNational Cancer Institute / NIH
  • 3:25 PMClosing remarks
    • Silvana LucianiUnit Chief, Noncommunicable Diseases (PAHO)


Time correspondence 


  • 11:00 am –  Los Angeles
  •   1:00 pm. –  Belmopan, Guatemala City, Managua, Mexico City, San José (CR), San Salvador, Tegucigalpa
  •   2:00 pm – Bogota, Panama City, Havana, Lima, Nassau, Port-au-Prince, Quito, Washington DC
  •   3:00 am. –  Bridgetown, Castries, Georgetown, Kingston, Port of Spain, San Juan
  •   4:00 pm. – Asunción, Brasilia, Buenos Aires, Montevideo, Paramaribo, Santiago
  •   8:00 pm. – Geneva, Madrid

For other cities, check the time in the following link